Kurozumi et al. [32] determined that PgR expression can be considered a significant prognostic indicator for assessing the long-term prognosis of ER-positive/HER2-negative BC, with an optimal cut-off value identified at 20%. The gene discussed is ERBB2; the disease is breast cancer.